Cullin 3 negatively regulates Cdc20 stability in prostate cancer. SPOP promotes Cdc20 poly-ubiquitination and degradation. Prostate cancer-associated mutants are defective in interaction with Cdc20. SPOP-deficient prostate cancer cells become resistant to Cdc20 inhibitor.